Merck announced that Frank Clyburn, executive vice president and president, Human Health, will leave Merck on Feb. 1, 2022, to assume a leadership opportunity with another company. Leadership of Human Health following Frank's departure will be announced in the coming weeks.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.6 USD | +0.04% | -1.96% | +17.02% |
05-02 | Merck: encouraging results in gastric cancer | CF |
05-01 | Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.02% | 323B | |
+31.52% | 690B | |
+24.24% | 546B | |
-5.21% | 358B | |
+5.01% | 287B | |
+13.94% | 235B | |
+5.01% | 199B | |
-10.18% | 195B | |
+3.98% | 161B | |
-2.19% | 159B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Frank Clyburn to Leave Merck